| Michelle Barr, MD | |
|
26 City Hall Mall, Medford, MA 02155 | |
| (781) 306-5100 | |
| Not Available |
| Full Name | Michelle Barr |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 26 City Hall Mall, Medford, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720142714 | NPI | - | NPPES |
| 2613985 | Other | MA | AETNA |
| 0130681 | Medicaid | MA | |
| J23106 | Other | MA | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 206499 (Massachusetts) | Primary |
| Entity Name | Atrius Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871639914 PECOS PAC ID: 4789588641 Enrollment ID: O20031121000582 |
News Archive
State executives ranging from Louisiana Gov. Bobby Jindal and Wisconsin Gov. Scott Walker to Indiana Gov. Mike Pence and Missouri Gov. Jay Nixon continue to wrestle with their plans regarding the expansion - and repercussions, in terms of public opinon, budgets and policy decisions - that are emerging as a result.
UCLA neuroscience researchers have successfully transferred the memory of one animal to another via injections of RNA. This futuristic study has made possible hopes for similar transfers among higher animals too including humans.
Therics, Inc., a subsidiary of Tredegar Corporation, announced that it has received FDA clearance to market a new resorbable beta-tricalcium phosphate bone void filler device used to treat osseous defects of the skeletal system.
The brains of Alzheimer patients have high accumulations of the material beta-amyloid, which appear in the form of plaques. The precursors of these plaques are believed to be the underlying cause of the nerve cell loss that leads to the disruptions in memory that characterize Alzheimer's disease. The main aim of many Alzheimer therapies is therefore to inhibit the formation of beta-amyloid. Since beta-amyloid is cleaved from the so-called amyloid precursor protein (APP), scientists have focused on stopping the two enzymes that attack the precursor protein. These act like molecular scissors and cut out the beta-amyloid fragment. Blocking these scissors precludes the formation of beta-amyloid.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Barr, MD 26 City Hall Mall, Medford, MA 02155 Ph: (781) 306-5100 | Michelle Barr, MD 26 City Hall Mall, Medford, MA 02155 Ph: (781) 306-5100 |
News Archive
State executives ranging from Louisiana Gov. Bobby Jindal and Wisconsin Gov. Scott Walker to Indiana Gov. Mike Pence and Missouri Gov. Jay Nixon continue to wrestle with their plans regarding the expansion - and repercussions, in terms of public opinon, budgets and policy decisions - that are emerging as a result.
UCLA neuroscience researchers have successfully transferred the memory of one animal to another via injections of RNA. This futuristic study has made possible hopes for similar transfers among higher animals too including humans.
Therics, Inc., a subsidiary of Tredegar Corporation, announced that it has received FDA clearance to market a new resorbable beta-tricalcium phosphate bone void filler device used to treat osseous defects of the skeletal system.
The brains of Alzheimer patients have high accumulations of the material beta-amyloid, which appear in the form of plaques. The precursors of these plaques are believed to be the underlying cause of the nerve cell loss that leads to the disruptions in memory that characterize Alzheimer's disease. The main aim of many Alzheimer therapies is therefore to inhibit the formation of beta-amyloid. Since beta-amyloid is cleaved from the so-called amyloid precursor protein (APP), scientists have focused on stopping the two enzymes that attack the precursor protein. These act like molecular scissors and cut out the beta-amyloid fragment. Blocking these scissors precludes the formation of beta-amyloid.
› Verified 4 days ago
John A Myers, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 124 Professors Row, Medford, MA 02155 Phone: 617-627-3350 | |
Thomas W Furth, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 781-306-5100 Fax: 781-306-5379 | |
Teresia T Pham, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 781-306-5100 | |
Dana Sackton, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 781-306-5437 Fax: 781-306-5234 | |
Stephanie Lee Bivona, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 101 Main St Ste 202, Medford, MA 02155 Phone: 781-396-1288 | |
Teresa Mary Zabik, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 781-306-5437 Fax: 781-306-5234 | |
Hongchao Zhou, Pediatrics Medicare: Medicare Enrolled Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 781-306-5437 Fax: 781-306-5234 |